Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials

被引:17
作者
Liu, Jie [1 ]
Yuan, Feixiang [1 ]
Gao, Jian [2 ]
Shan, Boer [3 ]
Ren, Yulan [3 ]
Wang, Huaying [3 ]
Gao, Ying [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China
[2] Fudan Univ, Affiliated Zhongshan Hosp, Dept Nutr, Shanghai 200433, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Dept Female Tumor, Shanghai 200433, Peoples R China
关键词
isoflavone supplementation; endometrial thickness; meta-analysis; randomized controlled trials; Gerotarget; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; CANCER-RISK; SOY PROTEIN; DNA METHYLATION; CLINICAL-TRIALS; HOT FLUSHES; BONE LOSS; BREAST; PHYTOESTROGENS;
D O I
10.18632/oncotarget.7959
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Isoflavone from soy and other plants modulate hormonal effects in women, and the hormone disorder might result in different caners including endometrial cancer. However, it's effect on the risk of endometrial cancer is still inconclusive. We aimed to assess the effects of isoflavone on endometrial thickness, a risk factor of endometrial cancer in peri-and post-menopausal women. Methods: A meta-analysis of randomized controlled trials was conducted to evaluate the effect of oral isoflavone supplementation on endometrial thickness in peri-and post-menopausal women. Electronic searches were performed on the PubMed, Embase, the Cochrane Library, web of science, CINAHL, and WHO ICTRP to August 1st, 2015. Reviews and reference lists of relevant articles were also searched to identify more studies. Summary estimates of standard mean differences (SMD's) and 95% CIs were obtained with random-effects models. Heterogeneity was evaluated with meta-regression and stratified analyses. Results: A total of 23 trials were included in the current analysis. The overall results did not show significant change of endometrial thickness after oral isoflavone supplementation (23 studies, 2167subjects; SMD:-0.05; 95% CI:-0.23, 0.13; P=0.60). Stratified analysis suggested that a daily dose of more than 54mg could decrease the endometrial thickness for 0.26mm (10 trials, 984subjects; SMD:-0.26; 95% CI:-0.45, -0.07; P=0.007). Furthermore, isoflavone supplementation significantly decrease the endometrial thickness for 0.23mm in North American studies (7 trials, 726 subjects; SMD:-0.23; 95% CI:-0.44, -0.01; P=0.04), but it suggested an increase for 0.23mm in Asian studies (3 trials, 224 subjects; SMD: 0.23; 95% CI:-0.04, 0.50; P=0.10). Conclusion: Oral isoflavone supplementation might have different effects in different populations and at different daily doses. Multiple-centre, larger, and long-term trials are deserved to further evaluate its effect.
引用
收藏
页码:17369 / 17379
页数:11
相关论文
共 50 条
[31]   Statins and risk of cancer: A meta-analysis of randomized, double-blind, placebo-controlled trials [J].
Kim, M. K. ;
Myung, S. K. ;
Tran, B. T. ;
Park, B. .
INDIAN JOURNAL OF CANCER, 2017, 54 (02) :470-477
[32]   Amantadine for Antipsychotic-Related Weight Gain Meta-Analysis of Randomized Placebo-Controlled Trials [J].
Zheng, Wei ;
Wang, Shibin ;
Ungvari, Gabor S. ;
Ng, Chee H. ;
Yang, Xin-Hu ;
Gu, Yu-Hong ;
Li, Ming ;
Xiang, Ying-Qiang ;
Xiang, Yu-Tao .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (03) :341-346
[33]   The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-Analysis of Randomized Placebo-Controlled Trials [J].
Ma, Hui ;
Huang, Yinglin ;
Cong, Zhengtu ;
Wang, Yuan ;
Jiang, Wenhai ;
Gao, Shuhe ;
Zhu, Gang .
JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (03) :915-937
[34]   Impact of exogenous testosterone on mood: A systematic review and meta-analysis of randomized placebo-controlled trials [J].
Amanatkar, Hamid R. ;
Chibnall, John T. ;
Seo, Byung-Woun ;
Manepalli, Jothika N. ;
Grossberg, George T. .
ANNALS OF CLINICAL PSYCHIATRY, 2014, 26 (01) :19-32
[35]   Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials [J].
Schneider, LS ;
Dagerman, K ;
Insel, PS .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (03) :191-210
[36]   Efficacy and safety of biologic agents for the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials [J].
Meng, Fanqiang ;
Li, Hui ;
Feng, Haoran ;
Long, Huizhong ;
Yang, Zidan ;
Li, Jiatian ;
Wang, Yuqing ;
Xie, Dongxing .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
[37]   Vitamin D and Muscle Health: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials [J].
Bislev, Lise Sofie ;
Grove-Laugesen, Diana ;
Rejnmark, Lars .
JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (09) :1651-1660
[38]   Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials [J].
Liu, Ting ;
Wang, Faping ;
Wang, Geng ;
Mao, Hui .
FRONTIERS OF MEDICINE, 2018, 12 (03) :340-349
[39]   Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials [J].
Vukadinovic, Davor ;
Scholz, Sean S. ;
Messerli, Franz H. ;
Weber, Michael A. ;
Williams, Bryan ;
Boehm, Michael ;
Mahfoud, Felix .
JOURNAL OF HYPERTENSION, 2019, 37 (10) :2093-2103
[40]   Folic acid supplementation and cancer risk: A meta-analysis of randomized controlled trials [J].
Qin, Xianhui ;
Cui, Yimin ;
Shen, Lin ;
Sun, Ningling ;
Zhang, Yan ;
Li, Jianping ;
Xu, Xin ;
Wang, Binyan ;
Xu, Xiping ;
Huo, Yong ;
Wang, Xiaobin .
INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (05) :1033-1041